Details of Major Bleeding Complications (WHO Grade 3 and 4) of 7 Patients in Group B
| Age (yr) . | FAB Type . | Chemotherapy Cycle . | Leukocytes (×109/L) . | Platelets (×109/L) . | Bleeding Site/WHO Grade . | Outcome . |
|---|---|---|---|---|---|---|
| 48 | M4 | Induction I | 40.5 | 58 | Diffuse bleeding during sepsis/3 | Resolved |
| 28 | M5 | Induction I | 16.0 | 53 | Vaginal bleeding 1 week postpartum/3 | Resolved |
| 29 | M4 | Induction II | 15.8 | 17 | Sigmoiditis with rectal bleeding/3 | Resolved |
| 64 | M4 | Induction I | 44.0 | 9 | Diffuse bleeding during sepsis/3 | Resolved |
| 42 | M2 | Consolidation I | <0.5 | 36 | Gastric ulcer and septic shock/4 | Died |
| 35 | M2 | Induction II | <1.0 | 13 | Rectal and vaginal bleeding/3 | Resolved |
| 50 | M4 | Induction I | <0.5 | 50 | Hemorrhagic diarrhea and septic shock/3 | Died |
| Age (yr) . | FAB Type . | Chemotherapy Cycle . | Leukocytes (×109/L) . | Platelets (×109/L) . | Bleeding Site/WHO Grade . | Outcome . |
|---|---|---|---|---|---|---|
| 48 | M4 | Induction I | 40.5 | 58 | Diffuse bleeding during sepsis/3 | Resolved |
| 28 | M5 | Induction I | 16.0 | 53 | Vaginal bleeding 1 week postpartum/3 | Resolved |
| 29 | M4 | Induction II | 15.8 | 17 | Sigmoiditis with rectal bleeding/3 | Resolved |
| 64 | M4 | Induction I | 44.0 | 9 | Diffuse bleeding during sepsis/3 | Resolved |
| 42 | M2 | Consolidation I | <0.5 | 36 | Gastric ulcer and septic shock/4 | Died |
| 35 | M2 | Induction II | <1.0 | 13 | Rectal and vaginal bleeding/3 | Resolved |
| 50 | M4 | Induction I | <0.5 | 50 | Hemorrhagic diarrhea and septic shock/3 | Died |